Olympus fires its CEO for alleged purchases of illegal drugs

The Japanese medical technology company Olympus announced this Monday the cessation of its until now CEO, Stefan Kaufmannafter investigating allegations that the executive “had purchased illegal drugs.”

In a statement, the Japanese firm explained that it decided to open an investigation after receiving an accusation about the alleged purchase of illegal drugs by Kaufmann.

“Based on the results of the investigation, the board of directors unanimously determined that Mr. Stefan Kaufmann likely engaged in conduct that was incompatible with our global code of conduct, our core values ​​and our corporate culture,” the company said.

As a result, the company asked Stefan Kaufmann to submit his resignation, which he did and was subsequently accepted by the Olympus board of directors.

In this sense, the Japanese firm has reported that Yasuo Takeuchi, CEO of Olympuswill perform the duties of CEO for the time being.

Olympus shares closed this Monday’s session with a fall of 5.64% on the Tokyo Stock Exchange, although they have appreciated 32% so far this year.